Department of Health Sciences, Bouvé College of Health Sciences, Northeastern University, 360 Huntington Avenue, Boston, MA, 02115, USA.
School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
J Gen Intern Med. 2023 Feb;38(2):414-420. doi: 10.1007/s11606-022-07760-6. Epub 2022 Aug 15.
The extent to which a positive delirium screening and new diagnosis of Alzheimer's disease or related dementias (ADRD) increases the risk for re-hospitalization, long-term nursing home placement, and death remains unknown.
To compare long-term outcomes among newly admitted skilled nursing facility (SNF) patients with delirium, incident ADRD, and both conditions.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study of Medicare beneficiaries who entered a SNF from hospital with a minimum 14-day stay (n = 100,832) from 2015 to 2016.
Return to home, hospital readmission, admission to a long-term care facility, or death.
Patients with delirium were as likely to be discharged home as patients diagnosed with ADRD (HR: 0.63, 95% CI: 0.59, 0.67; HR: 0.65, 95% CI: 0.64, 0.67). Patients with both delirium and ADRD were less likely to be discharged home (HR: 0.49, 95% CI: 0.47, 0.52) and showed increased risk of death (HR: 1.30, 95% CI: 1.17, 1.45). Patients with ADRD, regardless of delirium screening status, had increased risk for long-term nursing home care transfer (HR: 1.66, 95% CI: 1.63, 1.70; HR: 1.76, 95% CI: 1.69, 1.82). Patients with delirium and no ADRD showed increased risk of transfer to long-term nursing home care (HR: 1.25, 95% CI: 1.18, 1.33). The rate of deaths was higher among patients who screened positive for delirium without ADRD compared to the no delirium and no ADRD groups (HR: 2.35, 95% CI: 2.11, 2.61).
A positive delirium screening increased risk of death and transfer to long-term care in the first 100 days after admission regardless of incident ADRD diagnosis. Patients with delirium and/or ADRD also are less likely to be discharged home. Our study builds on the evidence base that delirium is important to address in older adults as it is associated with negative outcomes.
目前尚不清楚谵妄筛查呈阳性以及新诊断出的阿尔茨海默病或相关痴呆症(ADRD)是否会增加再次住院、长期护理院安置和死亡的风险。
比较新入院的康复护理机构(SNF)患者中伴有谵妄、新发 ADRD 以及同时伴有这两种情况的患者的长期结局。
设计、地点和参与者:这是一项回顾性队列研究,纳入了 2015 年至 2016 年期间至少入住康复护理机构 14 天的 Medicare 受益人的队列(n=100832)。
返回家中、再次入院、入住长期护理机构或死亡。
患有谵妄的患者与被诊断为 ADRD 的患者出院回家的可能性相同(HR:0.63,95%CI:0.59,0.67;HR:0.65,95%CI:0.64,0.67)。同时患有谵妄和 ADRD 的患者出院回家的可能性较低(HR:0.49,95%CI:0.47,0.52),并且死亡风险增加(HR:1.30,95%CI:1.17,1.45)。患有 ADRD 的患者,无论是否进行谵妄筛查,入住长期护理院的风险均增加(HR:1.66,95%CI:1.63,1.70;HR:1.76,95%CI:1.69,1.82)。患有谵妄但没有 ADRD 的患者入住长期护理院的风险增加(HR:1.25,95%CI:1.18,1.33)。与无谵妄且无 ADRD 组相比,无 ADRD 但谵妄筛查阳性的患者死亡率更高(HR:2.35,95%CI:2.11,2.61)。
在入院后 100 天内,谵妄筛查呈阳性无论是否新发 ADRD 诊断,均会增加死亡和转入长期护理的风险。患有谵妄和/或 ADRD 的患者出院回家的可能性也较低。我们的研究建立在这样的证据基础上,即谵妄是老年人的一个重要问题,因为它与不良结局有关。